Meredith Kaya | executive |
Cedric Francois | executive |
Adam Townsend | executive |
Timothy Sullivan | executive |
Jonathan Miller | analyst |
Tazeen Ahmad | analyst |
Anupam Rama | analyst |
Caroline Baumal | executive |
Annabel Samimy | analyst |
Yigal Nochomovitz | analyst |
Steven Seedhouse | analyst |
Colleen Hanley | analyst |
Philip Nadeau | analyst |
Siyue Wang | analyst |
Eliana Merle | analyst |
Joseph Stringer | analyst |
Derek Archila | analyst |
Douglas Tsao | analyst |
Graig Suvannavejh | analyst |
Good morning, ladies and gentlemen. Thank you for standing by, and welcome to the Apellis Pharmaceuticals Fourth Quarter 2023 Earnings Conference Call. [Operator Instructions]
Please be advised today's conference is being recorded.
I would now hand the conference over to your speaker host, Meredith Kaya, Senior Vice President Relations and Strategic Finance.